Compartir
Información de la revista
Número
Vol. 29. Núm. S3.Abstracts of the 2023 Annual Meeting of the ALEH
(diciembre 2024)
Abstracts of the 2024 Annual Meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
Ann Hepatol. 2024;29 Supl 3:101595
Acceso a texto completo
O-1 SIMULTANEOUS LIVER-KIDNEY TRANSPLANTATION OUTCOMES IN LATIN AMERICA
Jorge Carlos Martinez Morales, Valeria Descalzi, Elodie Hyppolito, Adriana Varon, Alina Zerega, Pedro Marin-Castro, Graciela Elia Castro Narro, Josefina Pages, ... Sebastián Marciano
Ann Hepatol. 2024;29 Supl 3:101595.1
Acceso a texto completo
O2- CHARACTERIZATION OF STEATOTIC LIVER DISEASE AND THE ROLE OF GENETIC BACKGROUND IN LATIN AMERICA
LUIS ANTONIO DÍAZ PIGA, Carolina Aguilera, Gustavo Ayares, Francisco Idalsoaga, Mauricio Pizarro, Fernando Javier Barreyro, Sebastián Marciano, Jorge Martínez Morales, ... Juan Pablo Arab
Ann Hepatol. 2024;29 Supl 3:101595.2
Acceso a texto completo
O3- RECOMPENSATION IN PATIENTS WITH CIRRHOSIS PRIOR TO FIRST LINE SYSTEMIC THERAPY IS ASSOCIATED WITH SIMILAR SURVIVAL OUTCOMES COMPARED TO COMPENSATED CIRRHOSIS
FEDERICO PIÑERO, Margarita Anders, Carla Bermúdez, Diego Arufe, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, ... Manuel Mendizabal
Ann Hepatol. 2024;29 Supl 3:101595.3
Acceso a texto completo
OP-1 LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: INTERIM 2-YEAR RESULTS FROM THE ASSURE STUDY
Palak J. Trivedi, Cynthia Levy, Kris V. Kowdley, Stuart C. Gordon, Christopher L. Bowlus, Maria Carlota Londoño Hurtado, Gideon M. Hirschfield, Aliya F. Gulamhusien, ... Charles A. McWherter
Ann Hepatol. 2024;29 Supl 3:101595.4
Acceso a texto completo
OP-2 WILSON DISEASE (WD) DIAGNOSIS WITH NEXT-GENERATION SEQUENCING (NGS) IN CLINICAL PRACTICE: A PILOT STUDY
Marta Mitiko Deguti, Michele Soares Gomes Gouvêa, Debora Raquel Benedita Terrabuio, Thiago Ferreira Araújo, Gilda Porta, Egberto Reis Barbosa, Eduardo Luiz Rachid Cançado
Ann Hepatol. 2024;29 Supl 3:101595.5
Acceso a texto completo
OP-3 ASSESSING TREATMENT ELIGIBILITY EXPANSION UNDER THE 2024 WHO GUIDELINES FOR CHRONIC HEPATITIS B
Manuel Mendizabal, Constanza D Sabate, Esteban Gonzalez Ballerga, Fernando Gruz, Ezequiel Ridruejo, Alejandro Soza, Jaime Poniachik, Grace Vergara, ... Sebastian Marciano
Ann Hepatol. 2024;29 Supl 3:101595.6
Acceso a texto completo
OP- 4 EPIDEMIOLOGY OF PRIMARY BILIARY CHOLANGITIS IN LATIN AMERICA: PRELIMINARY RESULTS FROM ALLATIN COHORT
Guilherme Grossi Lopes Cançado, Rafael Theodoro, Ezequiel Ridruejo, Lorena Castro Solari, Cristiane Alves Villela-Nogueira, Pablo Andres Coste Murillo, Harlim Rodríguez, Carlos Benítez Gajardo, ... Claudia Alves Couto
Ann Hepatol. 2024;29 Supl 3:101595.7
Acceso a texto completo
OP-5 ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) CRITERIA IN ALCOHOL-ASSOCIATED HEPATITIS: IMPLICATIONS FOR LIVER TRANSPLANTATION
LUIS ANTONIO DÍAZ PIGA, Paula Huerta, Renata Farias, Bastian Alcayaga, Francisco Idalsoaga, Gustavo Ayares, Jorge Arnold, María Ayala-Valverde, ... Juan Pablo Arab
Ann Hepatol. 2024;29 Supl 3:101595.8
Acceso a texto completo
OP-6 EVALUATION OF THE HEPATOPROTECTIVE ACTIVITY OF Flourensia cernua AND ITS IMPACT ON THE AEROBIC INTESTINAL MICROBIOTA IN A VALPROIC ACID-INDUCED DAMAGE MODEL IN WISTAR RATS
Liliana Torres González, José Miguel De la Rosa García, Jorge Martín Llaca Díaz, Lorena Salazar Cavazos, Humberto Rodríguez Rocha, Aracely García García, Catalina Leos Rivas, Veronica Mayela Rivas Galindo, ... Paula Cordero Pérez
Ann Hepatol. 2024;29 Supl 3:101595.9
Acceso a texto completo
OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles
MARIA AYALA VALVERDE, Jorge Arnold Alvarez, Gustavo Ayares, Francisco Barrera, Daniel Cabrera, Luis Antonio Diaz, Juan Pablo Arab, Ibon Martinez-Arranz, ... Marco Arrese
Ann Hepatol. 2024;29 Supl 3:101595.10
Acceso a texto completo
OP-8 SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADECUATE RESPONSE: ARE WE CHOOSING THE RIGHT TARGET POPULATION FOR CLINICALS TRIALS?
Daniela De La Viña, Natalia Sobenko, Eduardo Mullen, Ignacio Lucero, Juan Carlos Bandi, Maria Alejandra Villamil
Ann Hepatol. 2024;29 Supl 3:101595.11
Acceso a texto completo
OP-9 Assessing the Burden and Budget Impacts of HCV Elimination Strategies in Uruguay Using Decision-Analytic Modeling
Victoria Mainardi Rial, Daniela Olivari, Solange Gerona, Alec Aron, Huaiyang Zhong, Jagpreet Chhatwal, Lindsey Hiebert, John Ward
Ann Hepatol. 2024;29 Supl 3:101595.12
Acceso a texto completo
OP- 10 - NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: A COMPARATIVE ANALYSIS BETWEEN THE SPANISH AND LATINDILI NETWORKS
FERNANDO BESSONE, Ismael Alvarez Alvarez, Nelia Hernandez, Maria Isabel Schinoni, Inmaculada Medina Caliz, Hugo Tanno, Hao Niu, Maria Virginia Reggiardo, ... Raúl Jesus Andrade
Ann Hepatol. 2024;29 Supl 3:101595.13
Acceso a texto completo
OP- 11 Detection Strategy for Patients with Viral Hepatitis Using Laboratory Records of Blood Samples for HBsAg and HCV Antibodies: PANRELINK
Fernando Cairo, Lucia Navarro, Nicolas Dominguez, Ignacio Roca, Omar Galdame, Laura Gonzalez, Lucia Guillen, Stella Loudet, Manuel Barbero
Ann Hepatol. 2024;29 Supl 3:101595.14
Acceso a texto completo
O-12 DECIPHERING WILSON'S DISEASE IN COSTA RICA: AN INNOVATIVE GENETIC APPROACH
Danny Alvarado, Jorge Andres Herrera Corrales, Mildred Jimenez, Karina Hidalgo, Fernanda Vasquez, Francisco Vargas, Jorge Vargas, Francisco Hevia Urrutia
Ann Hepatol. 2024;29 Supl 3:101595.15
Acceso a texto completo
OP-13 CHOLANGIOCARCINOMA IN LATIN AMERICA: A MULTICENTER OBSERVATIONAL STUDY ALERTS ON ETHNICAL DISPARITIES IN TUMOR PRESENTATION AND OUTCOME
Leonardo G Da Fonseca, Laura Izquierdo Sanchez, Pedro H Hashizume, Yanina Carlino, Estefanía Liza Baca, Cristina Zambrano, Santiago Sepulveda, Andrea Bolomo, ... Jesus M Banales
Ann Hepatol. 2024;29 Supl 3:101595.16
Acceso a texto completo
OP- 14 ENHANCED MUSCLE MASS MITIGATES MASLD IN MYOSTATIN KNOCKOUT MICE WITHOUT IMPACTING EXERCISE PERFORMANCE
Daniel Cabrera Garcia, Faride Saud Zapura, Loreto Aguilar Barria, Marco Arrese, Luis Antonio Díaz, Juan Pablo Arab, Lisbell Estrada, Claudio Cabello Verrugio, ... Marcelo Andia
Ann Hepatol. 2024;29 Supl 3:101595.17
Acceso a texto completo
OP- 15 OUTCOME OF PREGNANCIES IN A SERIES OF WILSON DISEASE PATIENTS
Marta Mitiko Deguti, Debora Raquel Benedita Terrabuio, Fabiana Cordeiro Araújo, Gilda Porta, Egberto Reis Barbosa, Eduardo Luiz Rachid Cançado
Ann Hepatol. 2024;29 Supl 3:101595.18
Acceso a texto completo
OP-16 FREQUENCY OF ATP7B GENE MUTATIONS IN A BRAZILIAN COHORT OF PATIENTS WITH WILSON'S DISEASE
Maria Chiara Chindamo, Carla C. Judice, Marcia Angélica Bonilha Valladares, Bruno Pereira Ribeiro da Rocha, Eliane Almeida do Vale, Aline Moura Ferraz Pereira, Ubiratan Cassano Santos, Andreia Silva Evangelista, ... Renata de Mello Perez
Ann Hepatol. 2024;29 Supl 3:101595.19
Acceso a texto completo
P- 1 DEVELOPMENT OF LENTIVIRAL VECTORS FOR INHIBITION OF HEPATITIS B VIRUS, VIA SMALL INTERFERING RNA
Giovana Angelice Paula, Pedro Henrique da Conceição Roque, Rafaela de Sousa Moraes Pereira, Vanessa Salete de Paula, Fábio Luís Monteiro Lima, Lendel da Costa Correia, Amilcar Tanuri, Elen de Souza Mello, ... Bárbara do Lago Vieira
Ann Hepatol. 2024;29 Supl 3:101595.20
Acceso a texto completo
P-2 RECAM VS. RUCAM: ADVANCING THE DIAGNOSIS OF IDIOSYNCRATIC DILI WITH A REVISED ELECTRONIC APPROACH.
Sara Pillajo, Daniela Chiodi, Ximena Pazos, Adriana Sánchez, Inmaculada Medina-Cáliz, Fernando Bessone, María Isabel Lucena, Nelia Hernandez
Ann Hepatol. 2024;29 Supl 3:101595.21
Acceso a texto completo
P-3 FACTORS ASSOCIATED WITH AN IMPROVEMENT IN SEQUENTIAL LIVER STIFFNESS MEASURES BY TRANSIENT ELASTOGRAPHY IN MASLD PATIENTS WITH PREDIABETES AND TYPE 2 DIABETES.
Lorrane Viana Santos, Claudia Regina Lopes Cardoso, Gil Fernando Salles, Ana Carolina Cardoso, Cristiane Villela-Nogueira, Nathalie Carvalho Leite
Ann Hepatol. 2024;29 Supl 3:101595.22
Acceso a texto completo
P-4 HYPOTHERMIC OXYGENATED PERFUSION USING AN ECMO DEVICE IN LIVER TRANSPLANTATION: AN ANALYSIS OF THE FIRST 100 CASES AT A CHILEAN PUBLIC HOSPITAL
FRANCISCA MAGDALENA MARTÍNEZ VENEZIAN, Elizabeth Rivas, Valeria Galaz, Valentina Castillo, Julio Benitez, Edmundo Martinez, Rodrigo Wolff, Blanca Norero, ... Rolando Rebolledo
Ann Hepatol. 2024;29 Supl 3:101595.23
Acceso a texto completo
P-5 A LARGE REGISTER OF LIVER STIFFNESS AND STEATOSIS BY TRANSIENT ELASTOGRAPHY IN METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE – THE FIRST STEP FOR AN ADEQUATE PATIENT ALLOCATION
Ana Carolina Cardoso, João Marcello De Araújo Neto, Pedro Miguel Mattos Nogueira, Nathalie Carvalho Leite, Cristiane Villela-Nogueira
Ann Hepatol. 2024;29 Supl 3:101595.24
Acceso a texto completo
P-6 CORRELATION BETWEEN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AND FIBROSIS DEGREE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC)
Cristian Yamín Sánchez Sánchez, Diego Fernando Abendaño Rivera, Viridiana López Ladrón De Guevara, María Argentina Díaz Castro, Fátima Higuera de da Tijera, Carolina Guzmán Arriaga, Ángel Daniel Santana Vargas, José Luis Pérez Hernández
Ann Hepatol. 2024;29 Supl 3:101595.25
Acceso a texto completo
P-7 EPIDEMIOLOGY OF AUTOIMMUNE HEPATITIS IN LATIN AMERICA: PRELIMINARY RESULTS FROM ALLATIN COHORT
Guilherme Grossi Lopes Cançado, Ludmila Resende Guedes, Ezequiel Ridruejo, Lorena Castro Solari, Debora Raquel Benedita Terrabuio, Emilia Vera, Harlim Rodríguez, Pablo Andres Coste Murillo, ... Claudia Alves Couto
Ann Hepatol. 2024;29 Supl 3:101595.26
Acceso a texto completo
P-8 TRENDS IN ALCOHOL-ASSOCIATED CIRRHOSIS IN CHILE: A POPULATION STUDY BETWEEN 2001 TO 2020.
Ignacio Alarcón, Susana Mondschein, Alvaro Urzua, Juan ROBLERO CUM
Ann Hepatol. 2024;29 Supl 3:101595.27
Acceso a texto completo
P-9 SURVIVAL ANALYSIS OF A BRAZILIAN COHORT OF PATIENTS WITH WILSON DISEASE
Maria Chiara Chindamo, Vivian Rotman, Nathalia Carrano Eduardo de Castro, Debora Canoilas, Ubiratan Cassano Santos, Andreia Silva Evangelista, Fernanda Luiza Valladares Calçado, Leticia Cancella Nabuco, Renata de Mello Perez
Ann Hepatol. 2024;29 Supl 3:101595.28
Acceso a texto completo
P-10 SEROPREVALENCE OF CHRONIC HEPATITIS C INFECTION AND VIROLOGICAL CURE WITH A DAILY ADMINISTRATION SYSTEM OF NS3/4A PROTEASE INHIBITOR AND NS5A INHIBITOR IN IMPRISONED PATIENTS.
VÍCTOR MANUEL FONG FLORES, Omar Perez Carreon, Andres Flores Gomez, Andres Murillo Gallo, Alfredo Ojeda Garmendia, Mariana Marquez
Ann Hepatol. 2024;29 Supl 3:101595.29
Acceso a texto completo
P-11 REAL-WORLD DATA WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS IN LATINAMERICA: PRELIMINARY RESULTS OF THE SVR10K STUDY
Mario Alvares da Silva, Fatima Higuera de la Tijera, Miguel Castruita Garcia, Oscar Beltran Galvis, Ming Lung Yu, Soo Aleman, Grace Lai-Hung Wong, Javier Garcia Samaniego, ... Yu Jun Wong
Ann Hepatol. 2024;29 Supl 3:101595.30
Acceso a texto completo
P-12 METHYL GROUP DONOR SUPPLEMENTATION IN A MetALD MODEL: REGULATION OF GUT MICROBIOTA AND METABOLIC PARAMETERS
Carolina Díaz Canul, Angel Omar Vázquez Esqueda, Rebeca Rosas Campos, Rebeca Escutia Gutiérrez, Natalia Gómez Gómez, Monica Ibarra Hernández, Marina Galicia Moreno, Juan Armendáriz Borunda, Ana Sandoval Rodriguez
Ann Hepatol. 2024;29 Supl 3:101595.31
Acceso a texto completo
P-13 EVALUATION OF UNDIAGNOSED ALCOHOLIC LIVER DISEASE IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE USING THE ANI SCORE
Carlos Alventosa Mateu, Mercedes Latorre Sánchez, Inmaculada Castelló Miralles, Benjamín Climent Díaz, Juan José Urquijo Ponce, Moisés Diago Madrid
Ann Hepatol. 2024;29 Supl 3:101595.32
Acceso a texto completo
P-14 DETECTION OF CIRRHOSIS DUE TO ALPHA-1 ANTITRYPSIN DEFICIENCY IN ADULTS: PHENOTYPE STUDY IN COSTA RICA
Fernanda Vásquez Carit, Francisco Hevia Urrutia, Jorge Vargas Madrigal, Mildred Jiménez Hernández, Natassia Camacho Matamoros, Danny Alvarado Romero, Jorge Herrera Corrales
Ann Hepatol. 2024;29 Supl 3:101595.33
Acceso a texto completo
P- 15 GENETIC AND CLINICAL CHARACTERISTICS IN LEAN MASLD PATIENTS WITH AND WITHOUT CIRRHOSIS IN LATINOAMERICAN POPULATION
Karina Sato Espinoza, Javier Díaz Ferrer, Domingo Balderramo, Jhon Prieto Ortiz, Marco Arrese, Enrique Carrera Estupiñan, Angelo Zamban De Mattos, Jose Debes
Ann Hepatol. 2024;29 Supl 3:101595.34
Acceso a texto completo
P-16 UNLOCKING S-PINDOLOL'S POTENTIAL FOR MASLD: BENEFICIAL EFFECTS ON MUSCLE MASS AND FUNCTION AND LIVER HISTOLOGY IN WESTERN- DIET FED MICE
Daniel Cabrera, Loreto Aguilar, Faride Saud, Lisbell Estrada, Marcelo Andia, Marco Arrese, Juan Pablo Arab, Luis Antonio Diaz, ... Claudio Cabello-Verrugio
Ann Hepatol. 2024;29 Supl 3:101595.35
Acceso a texto completo
P-17 AMIKACIN USE AND RISK OF NEPHROTOXICITY IN PATIENTS WITH LIVER CIRRHOSIS HOSPITALIZED FOR SEPSIS
Alonso Saez, Carlos Padilla, Daniela Simian, Juan Medel, Gabriel Mendez, María Gómez, Alvaro Urzúa, Juan Pablo Roblero, Jaime Poniachik
Ann Hepatol. 2024;29 Supl 3:101595.36
Acceso a texto completo
P-18 ANTI-HBC POSITIVITY IS AN INDEPENDENT PREDICTIVE FACTOR FOR HCC DEVELOPMENT AND SHOULD BE INCORPORATED TO THE HCC RISK SCORE PREDICTION MODEL IN ADVANCED FIBROSIS
Marcus Vinicius de Acevedo Garcia Gomes, Diogo Delgado Dotta, Manuella Andrade Oliveira Sobral, Isabela Bodaczny Taliberti, Alexandre Belucci Trazzi, Eduardo Pombo Nascimento, Betania da Silva Rocha, Patricia Momoyo Yoshimura Zitelli, ... Mario Guimaraes Pessoa
Ann Hepatol. 2024;29 Supl 3:101595.37
Acceso a texto completo
P-19 ASSOCIATION OF TM6SF2 GENE POLYMORPHISMS WITH CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN A HISPANIC ADULT POPULATION
LUISA FERNANDA SANTOS CUERVO, Maria Claudia Noguera Santamaria, Carlos Andres Ortiz Trujillo, Fernando Suarez Obando, Adriana Varon Puerta
Ann Hepatol. 2024;29 Supl 3:101595.38
Acceso a texto completo
P-20 HIGH PREVALENCE OF CHRONIC HEPATITIS B IN ACHE COMMUNITIES IN THE DEPARTMENT OF CANINDEYU-PARAGUAY
Sebastián Díaz Duba, Marcos Girala Salomon, Guillermo Fernandez, Sara Melgarejo, Karina Riquelme, Sergio Morinigo, Claudia Crovato, Sebastián Burró, ... Jesús Ortiz Villalba
Ann Hepatol. 2024;29 Supl 3:101595.39
Acceso a texto completo
P-21 THE ROLE SP-INDUCED MAST CELL ACTIVATION IN LIVER FIBROSIS
Larissa Aleman Franco, Beatriz Gárate Pérez De Tudela, Bárbara Castro Rebolledo, Elisa Balboa Castillo, Jaime Poniachik Teller, Caroll J Beltrán Muñoz
Ann Hepatol. 2024;29 Supl 3:101595.40
Acceso a texto completo
P-22 URINARY BIOMARKER NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) FOR IDENTIFYING ACUTE KIDNEY INJURY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS AND CIRRHOSIS
Cristian Yamín Sánchez Sánchez, Diego Fernando Abendaño Rivera, Ximena Elizabeth Cuenca Ávila, Fátima Higuera De La Tijera, Carolina Guzmán Arriaga, Ángel Daniel Santana Vargas, José Luis Pérez Hernández
Ann Hepatol. 2024;29 Supl 3:101595.41
Acceso a texto completo
P-23 PORTAL VEIN THROMBOSIS IS ASSOCIATED WITH HEPATIC DECOMPENSATIONS WITHOUT LIVER STIFFNESS INCREASE IN HEPATOSPLENIC SCHISTOSOMIASIS
Rafael Theodoro, Guilherme Grossi Lopes Cançado, Mateus Jorge Nardelli, Guilherme Augusto Lima Figueira, Carlos Eduardo Franca Vargas, Ludmila Resende Guedes, Fernanda Maria Farage Osório, Luciana Costa Faria, Claudia Alves Couto
Ann Hepatol. 2024;29 Supl 3:101595.42
Acceso a texto completo
P-24 DESCRIPTION OF SERUM MICRORNAS EXPRESSION AMONG INDIVIDUALS WITH VIRAL HEPATITIS AND LONG COVID
Lucas da Silva Lima, Juliana Maul Cardoso, Iolanda Raquel Paulo Ferreira, Luciane Leon Almeida Amado, Otacilio Moreira Da Cruz, Wagner Luis Coelho da Costa Nunes Pimentel, Lia Lewis Laura, Vanessa Salete De Paula, ... Livia Villar Melo
Ann Hepatol. 2024;29 Supl 3:101595.43
Acceso a texto completo
P-25 IMPEDANCE CARDIOGRAPHY AND SPLEEN STIFFNESS MEASUREMENT TO ASSESS THERAPEUTIC RESPONSE IN CIRRHOTIC PATIENTS TREATED WITH NON-CARDIOSELECTIVE BETA-BLOCKERS
Martín Elizondo Barceló, Andreína Tesis Montes, Marcelo Valverde Gómez, Ricardo Armentano Feijoo, Solange Gerona Sangiovanni
Ann Hepatol. 2024;29 Supl 3:101595.44
Acceso a texto completo
P-26 EPIGENETIC MARKS IN PATIENTS WITH SUSTAINED VIRAL RESPONSE TO HCV AND RESIDUAL LIVER FIBROSIS ARE RESTORED BY PROLONGED-RELEASE PIRFENIDONE
Eira Cerda Reyes, Ricardo De la Rosa Bibiano, Ana Sandoval Rodriguez, Rebeca Rosas Campos, Rebeca Escutia Gutiérrez, Ángel Omar Vázquez Esqueda, Stefanny Cornejo Hernández, Alejandro Gutiérrez Átemis, ... Juan Armendáriz Borunda
Ann Hepatol. 2024;29 Supl 3:101595.45
Acceso a texto completo
P-27 OBESITY AND LIVER STEATOSIS IN ADOLESCENTS AND YOUNG ADULTS - RELATED FACTORS AND THE IMPACT OF LIFESTYLE
Fabiana Martins Basilio, Ana Carolina Cardoso, Katia Bloch, Nathalie Leite, Cristiane Villela-Nogueira
Ann Hepatol. 2024;29 Supl 3:101595.46
Acceso a texto completo
P-28 CHARACTERIZATION OF CHRONIC LIVER DISEASE, CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA PROGRESSION IN A COLOMBIAN HEALTH MAINTENANCE ORGANIZATION: A TEN-YEAR RETROSPECTIVE STUDY
Joshua Kock Sierra, Juan Felipe Betancur, Jhon Edward Bolaños, Luz Eugenia Perez, Carlos José Bello, Farley Johanna Gonzalez, Jose Sanabria, Carlos Badillo
Ann Hepatol. 2024;29 Supl 3:101595.47
Acceso a texto completo
P-29 DIFFERENCES IN THE PROGRESSION OF BODY COMPOSITION AND LIVER DAMAGE IN A MURINE MODEL OF METABOLIC SYNDROME: A SEX PERSPECTIVE
Laura Manjarrés, Aline Xavier, Leticia González, Camila Garrido, Flavia Zacconi, Carlos Sing-Long, Marcelo Andia
Ann Hepatol. 2024;29 Supl 3:101595.48
Acceso a texto completo
P-30 NURSING EXPERIENCE IN THE ONLY ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANT PROGRAM IN COLOMBIA
ANA MARÍA MARTINEZ CAMARGO, Yesica Juliana Castellanos Menjura, Lina Marcela Ruiz Ramírez, Angélica María Sanabria Jiménez, Gilberto Andrés Mejia Hernández, Adriana Varón Puerta
Ann Hepatol. 2024;29 Supl 3:101595.49
Acceso a texto completo
P-31 ACUTE LIVER FAILURE DUE TO WILSON'S DISEASE IN COSTA RICA: A LOOK AT GENETICS
Jorge Andres Herrera Corrales, Francisco Hevia Urrutia, Danny Alvarado, Fernanda Vasquez Carit, Francisco Vargas Navarro, Jorge Eduardo Vargas Madrigal, Karina Hidalgo, Mildred Jimenez
Ann Hepatol. 2024;29 Supl 3:101595.50
Acceso a texto completo
P-32 ACCESSIBILITY TO SEQUENTIAL SYSTEMIC TREATMENT AFTER TACE: IMPACT ON SURVIVAL IN A LATIN AMERICAN PROSPECTIVE COHORT
FEDERICO PIÑERO, Margarita Anders, Carla Bermúdez, Diego Arufe, Adriana Varón, Ana Palazzo, Jorge Rodríguez, Oscar Beltrán, ... Manuel Mendizabal
Ann Hepatol. 2024;29 Supl 3:101595.51
Acceso a texto completo
P-33 COMBINATION OF FIB-4 SCORE AND D-DIMER TO PREDICT OUTCOME IN HOSPITALIZED COVID-19 PATIENTS
Fernanda Pozzobon Manhães, Maria Chiara Chindamo, Renata Perez de Mello, Ronir Luiz Raggio, Maria Paula Cunha Fontes Raymundo, Julia Parente Gomes, Taisa Garilha Melo
Ann Hepatol. 2024;29 Supl 3:101595.52
Acceso a texto completo
P-34 ALBUMIN-BILIRUBIN GRADE ANALYSIS OF OVERALL SURVIVAL WITH ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA
Cristina Cheinquer Coelho Borges, Alexandre de Araújo, Mario Alvares-da-Silva Reis, Rui Weschenfelder, Hugo Cheinquer
Ann Hepatol. 2024;29 Supl 3:101595.53
Acceso a texto completo
P-35 CLINICAL AND EPIDEMIOLOGICAL DIFFERENCES BETWEEN PATIENTS MONOINFECTED WITH HEPATITIS B AND COINFECTED WITH HEPATITIS DELTA IN A HYPERENDEMIC REGION OF HEPATITIS B
Walter Silva Junior Junior, Jadson Dourado Costa, Ingrid Laise Vivas, Sidelcina Rugieri Pacheco, Ezequiel Ridruejo, Juan Salcedo, Deusilene Souza Dallacqua, Raymundo Paraná, Maria Izabel Schinoni
Ann Hepatol. 2024;29 Supl 3:101595.54
Acceso a texto completo
P-36 THE PROGNOSTIC ROLE OF NEUTROPHIL-LYMPHOCYTE RATIO IN PATIENTS WITH ALCOHOLIC HEPATITIS
Moises Coutiño Flores, Jesús Ignacio Mazadiego Cid, Katy Alejandra Sanchez Pozos, Rogelio Zapata Arenas, Antonio Coutiño Flores, Maria Del Rosario Herrero Maceda, Scherezada Maria Isabel Mejia Loza
Ann Hepatol. 2024;29 Supl 3:101595.55
Acceso a texto completo
P-37 ENHANCED DIAGNOSTIC ACCURACY OF FIB-4 WITH M30 FOR IDENTIFYING AT-RISK PATIENTS WITH STEATOTIC LIVER DISEASE
Camila Avilés, Paula Rivera, Nancy Solís, Paula Huerta, Jorge Arnold, Gustavo Ayares, Francisco Idalsoaga, Francisco Barrera, ... Luis Antonio Díaz
Ann Hepatol. 2024;29 Supl 3:101595.56
Acceso a texto completo
P-38 EVALUATION OF THE GENETIC AND VIROLOGICAL PROFILE OF PREGNANT WOMEN INFECTED WITH HEPATITIS B AND C VIRUSES IN A REFERENCE CENTER IN RIO DE JANEIRO, BETWEEN 2016 AND 2022
Kaio Ferreira Callebe Pedro, Vinicius Mello Motta, Giovana Nascimento Guimarães Santos, Giovana Angelice Paula, Paulo Sergio Sousa Fonseca, Aryele Raíra Pereira da Silva, Nathalia Balassiano, Caroline Baldin, ... Lia Laura Lewis-Ximenez
Ann Hepatol. 2024;29 Supl 3:101595.57
Acceso a texto completo
P-39 PREVALENCE AND FACTORS ASSOCIATED WITH TREATMENT ADHERENCE IN LIVER TRANSPLANT PATIENTS ATTENDED AT LACARDIO, BOGOTÁ, COLOMBIA
Oscar Alfredo Beltran Galvis, Maria Elena Ramos Cifuentes, Juliana Chaves Ceron, Aura Islena Blanco Torres, Angelica Maria Sanabria Jiménez
Ann Hepatol. 2024;29 Supl 3:101595.58
Acceso a texto completo
P-40 ASSOCIATION BETWEEN LIVER STIFFNESS MEASUREMENTS USING MR ELASTOGRAPHY AND PORTOSYSTEMIC SHUNTS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
Rodrigo Pereira Luz Pereira, Cristiane Nogueira Villela, Juliana Mesiano, Guilherme Cunha Moura
Ann Hepatol. 2024;29 Supl 3:101595.59
Acceso a texto completo
P-41 MICRORNAs FROM EVs AS POTENTIAL LIVER FIBROSIS NON-INVASIVE BIOMARKERS IN CHRONIC HEPATITIS C
Victoria Cairoli, Marcela De Sousa, Jean Carla Sejas, María Victoria Preciado, Pamela Valva
Ann Hepatol. 2024;29 Supl 3:101595.60
Acceso a texto completo
P-42 ASSESSING THE TRAINING NEEDS OF PERUVIAN HEALTHCARE PROFESSIONALS
CESAR CASTRO VILLALOBOS, Rommel Zambrano Huilla, Rosario Mayorga Márquez, Jorge Garavito Rentería, Luis Antonio Díaz Piga
Ann Hepatol. 2024;29 Supl 3:101595.61
Acceso a texto completo
P-43 PROGNOSTIC MODELS AFTER TRANSARTERIAL CHEMOEMBOLIZATION IN A LATIN AMERICAN PROSPECTIVE COHORT STUDY
FEDERICO PIÑERO, Margarita Anders, Carla Bermudez, Ezequiel Demirdjian, Adriana Varón, Dolores Murga, Jorge Rodriguez, Oscar Beltrán, ... Manuel Mendizabal
Ann Hepatol. 2024;29 Supl 3:101595.62
Acceso a texto completo
P-44 LONG-TERM SURVIVAL IN PATIENTS WITH LIVER TRANSPLANTATION
MARCIA SAMADA SUAREZ, Sheyla Moret Vara, Kenia Valenzuela Aguilera, Julio César Hernández Perera, Alejandro Roque Valdez, Norlan Bressler Hernández, Raimundo Blanco Selles, Maricet Fernández Díaz, ... Mirtha Infante Velazquez
Ann Hepatol. 2024;29 Supl 3:101595.63
Acceso a texto completo
P-45 ANALYSIS OF SURVIVAL RATE AND FACTORS ASSOCIATED WITH LIVER RETRANSPLANTATION: 18-YEAR EXPERIENCE IN BOGOTÁ - COLOMBIA
Andres Dueñas, Angelica Sanabria, Estefania Cristancho, Gilberto Mejia, Adriana Varon
Ann Hepatol. 2024;29 Supl 3:101595.64
Acceso a texto completo
P-46 IMMUNOSUPPRESSION IN POST LIVER TRANSPLANTATION: REVIEW OF THE EXPERIENCE IN A CHILEAN UNIVERSITY HOSPITAL
Richard Esteban Martinez Ruiz, Renato Francisco Palma Fernandez, Rodrigo Mauricio Wolff Rojas
Ann Hepatol. 2024;29 Supl 3:101595.65
Acceso a texto completo
P-47 DEGREES OF LIVER STIFFNESS AND STEATOSIS AS PREDICTORS OF PREECLAMPSIA COMPLICATIONS
Jose Luis Perez Hernandez, Andres Tonatihu Flores Flores, Daniel Santana Vargas, Orestes de Jesus Cobos Quevedo, Jesus Carlos Briones Garduño, Fatima Higuera de la Tijera
Ann Hepatol. 2024;29 Supl 3:101595.66
Acceso a texto completo
P-48 COMPARISON OF THE ALBI MODEL (ALBUMIN/BILIRUBIN INDEX) WITH ESTABLISHED SCALES AS PREDICTOR OF RESPONSE TO STEROID TREATMENT IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS
CLAUDIA LETICIA DORANTES NAVA, Maria de Fatima Higuera de la Tijera, Juan Carlos Silis Cravioto, Julio Cesar Zavala Castillo, Miguel Yael Carmona Castillo, Ernesto Javier Medina Avalos, Sandra Teutli Carrion, Raquel Yazmin Lopez Perez
Ann Hepatol. 2024;29 Supl 3:101595.67
Acceso a texto completo
P-49 EFFECT OF STATINS IN REVERSING CELL GROWTH DYSREGULATION IN THE EARLY STAGES OF HEPATOCARCINOGENESIS
Lucia Coli, Giselle Romero Caimi, Facundo Diaz Kozak, Zahira Deza, Laura Alvarez, Ezequiel Ridruejo
Ann Hepatol. 2024;29 Supl 3:101595.68
Acceso a texto completo
P-50 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS WITH ACUTE HEPATITIS B VIRUS IN A PUBLICAL HOSPITAL IN CHILE FROM 2015 TO 2022.
Herman Aguirre Barahona, Marisol Arratia Pinto, Javier Perez Valenzuela, Belen Soler Masferrer, Camila Lazcano Jorquera, Joaquin Thomas Pozo, Lilian Isla Montoya, Gabriel Mezzano Puentes
Ann Hepatol. 2024;29 Supl 3:101595.69
Acceso a texto completo
P-51 TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS), EXPERIENCE IN A UNIVERSITY CENTER
Caterina Chesta Alegría, Álvaro Urzúa Manchego, Víctor Henríquez Auba, Patricio Palavecino Rubilar, Nicolás Martínez Roje, Tomás Cermenati Bahrs, Claudio Lema Olivares, Máximo Cattaneo Buteler, ... Jaime Poniachik Teller
Ann Hepatol. 2024;29 Supl 3:101595.70
Acceso a texto completo
P-52 CHARACTERIZATION OF SERUM METABOLOMIC PROFILE BY NMR IN PATIENTS WITH VARIOUS DEGREES OF HEPATIC ENCEPHALOPATHY.
Paula Cordero Pérez, Ricardo Andrés Gómez Quiroz, Luis Andrés González Torres, Ernesto Sánchez Mendoza, Diana Patricia Moreno Peña, Liliana Torres Gonzalez, Linda Elsa Muñoz Espinosa, Alma Leticia Saucedo Yáñez
Ann Hepatol. 2024;29 Supl 3:101595.71
Acceso a texto completo
P-53 IMMUNE-MEDIATED ADVERSE EVENTS FOLLOWING ATEZOLIZUMAB PLUS BEVACIZUMAB IS ASSOCIATED WITH DECREASED SURVIVAL IN PATIENTS WITH CIRRHOSIS
FEDERICO PIÑERO, Margarita Anders, Carla Bermúdez, Ezequiel Demirdjian, Adriana Varón, Daniela Perez, Jorge Rodriguez, Oscar Beltrán, ... Manuel Mendizabal
Ann Hepatol. 2024;29 Supl 3:101595.72
Acceso a texto completo
P-54 ANALYSIS OF FACTORS ASSOCIATED WITH STEATOTIC LIVER DISEASE IN SUBJECTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE CROSS-SECTIONAL STUDY IN THE CHILEAN POPULATION
Diego Motto Arriaza, Andres Acosta Garay, Richard Martinez Ruiz, Barbara Riffo Vicencio, Manuel Alvarez Lobos, Francisco Barrera Martinez, Cristian Hernandez Rocha, Carolina Pavez Ovalle, ... Marco Arrese Jimenez
Ann Hepatol. 2024;29 Supl 3:101595.73
Acceso a texto completo
P-55 FIRST EVALUATION ALBI SCORE COULD BE A TOOL FOR RISK STRATIFICATION OF HCC DEVELOPMENT IN PATIENTS WITH CHRONIC HEPATITIS C AND CIRRHOSIS
Claudia Maccali, Isabel Veloso Pereira, Lisa RC Saud, Regiane SSM Alencar, Arthur IN Oliveira, Jose Tadeu Stefano, Aline L Chagas, Mario G Pessoa, Claudia P Oliveira
Ann Hepatol. 2024;29 Supl 3:101595.74
Acceso a texto completo
P-56 EXPERIENCE WITH DEXMEDETOMIDINE IN THE MANAGEMENT OF ALCOHOL WITHDRAWAL SYNDROME FOR PATIENTS WITH CIRRHOSIS
Liliana Ivonne Gallardo Gonzalez, Jose Luis Perez Hernandez, Maria Fatima Higuera de la Tijera
Ann Hepatol. 2024;29 Supl 3:101595.75
Acceso a texto completo
P-57 SUSCEPTIBILITY PATTERNS AND EMPIRICAL ANTIBIOTIC GUIDANCE FOR URINARY TRACT INFECTIONS IN PATIENTS WITH CIRRHOSIS
Carolina Vazquez, Gonzalo Gomez Perdiguero, Esteban Gonzalez Ballerga, Ilse Sorena Pardo Ivirico, Agustin Di Santo, Camila Maria Briz, Maria Dolores Murga, Ana Palazzo, ... Sebastian Marciano
Ann Hepatol. 2024;29 Supl 3:101595.76
Acceso a texto completo
P-58 PILOT STUDY OF HEPATITIS E VIRUS SEROPREVALENCE IN HEPATITIS B AND DELTA CARRIERS IN THE WESTERN AMAZON
Caio Lopes Borges Andrade, Luiz Felipe Monteiro Darzé, Maurício de Souza Campos, Sidelcina Rugieri Pacheco, Ezequiel Ridruejo, Juan Miguel Villalobos Salcedo, Katia Ingred da Silva Maia, Tárcio Peixoto Roca, ... Maria Izabel Schinoni
Ann Hepatol. 2024;29 Supl 3:101595.77
Acceso a texto completo
P-59 SOCIAL DETERMINANTS OF HEALTH AND INEQUITIES IN CHRONIC DISEASES: THE CASE OF LIVER DISEASES
Luisa Fernanda Santos Cuervo, Adriana Varon Puerta
Ann Hepatol. 2024;29 Supl 3:101595.78
Acceso a texto completo
P-60 CAN A DOPPLER ULTRASOUND PREDICT VARICEAL HEMORRHAGE AND CORRELATE WITH THE MELD 3.0 SCORE IN LIVER CIRRHOSIS PATIENTS? A RETROSPECTIVE STUDY
Lucia Amairani Robles Casanova, Gabriela Bretón Arroy, Maria Rosario Herrero Maceda, Scherezada Maria Isabel Mejía Loza
Ann Hepatol. 2024;29 Supl 3:101595.79
Acceso a texto completo
P-61 CLINICAL APPLICATION OF NAFLD FIBROSIS SCORE AND HEPAMET FIBROSIS SCORE IN CORONARY ARTERY DISEASE AND MASLD: A CROSS-SECTIONAL STUDY IN WESTERN MEXICAN POPULATION
José Antonio Velarde Chávez, Francisco Alejandro Félix Téllez, Jorge Alberto Martínez Ortiz, Neisser Morales Victorino, Claudia Ximena Vásquez Veloza, Diana Karen Tapia Calderón, José Roberto Barrientos Avalos, José Antonio Velarde Ruiz Velasco
Ann Hepatol. 2024;29 Supl 3:101595.80
Acceso a texto completo
P-62 SARCOPENIA AND PSOAS MUSCLE DENSITY ARE INDEPENDENT PREDICTORS OF SURVIVAL OF LIVER TRANSPLANT RECIPIENTS
CARLOS BENÍTEZ GAJRADO, Matías Hernández, Cecilia Besa
Ann Hepatol. 2024;29 Supl 3:101595.81
Acceso a texto completo
P-63 CHARACTERISTICS AND CLINICAL OUTCOMES IN CIRRHOTIC PATIENTS TREATED IN ICU BETWEEN 2018-2023
Daniel Rojas Kozhakin, Juan Linares, Maria Rincon, Angelica Sanabria, Adriana Varon Puerta
Ann Hepatol. 2024;29 Supl 3:101595.82
Acceso a texto completo
P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITAL
Juan Ignacio Marin-Zuluaga, Andres Fernando Rodriguez-Gutierrez, María Fernanda Saavedra-Chacón, Christian Ernesto Melgar-Burbano
Ann Hepatol. 2024;29 Supl 3:101595.83
Acceso a texto completo
P-65 NEOPORTA WITH OR WITHOUT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AS A VIABLE TREATMENT OF CHRONIC PORTAL VEIN THROMBOSIS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS
Issac Octavio Vargas Olmos, Graciela Elia Castro Narro, Aldo Torre Delgadillo, Jose Antonio Cienfuegos Alvear, Elsie Daniela Sánchez Sánchez
Ann Hepatol. 2024;29 Supl 3:101595.84
Acceso a texto completo
P-66 INCIDENCE AND FACTORS ASSOCIATED WITH ONE-YEAR POST-LIVER TRANSPLANT REJECTION AND MORTALITY, A COHORT STUDY
Vicente Arancibia Aguilera, Jaime Poniachik Teller, Daniela Simian Marin, Máximo Cattaneo Buteler, Álvaro Urzúa Manchego, MATÍAS MARTÍNEZ OLGUÍN
Ann Hepatol. 2024;29 Supl 3:101595.85
Acceso a texto completo
P-67 FREQUENCY OF MASLD IN INFLAMMATORY BOWEL DISEASE
JAIME ISRAEL CERVANTES CONTRERAS, Graciela Elia Castro Narro, Abdiel Esaú Moreno González, Sophia Eugenia Martínez Vázquez, Miriam Bastida Osorio, Carolina Ivette Zubía Nevárez, Martha Alejandra Fernández Galindo, Luisangela Meza López, Jesús Kazuo Yamamoto Furusho
Ann Hepatol. 2024;29 Supl 3:101595.86
Acceso a texto completo
P-68 LIVGUARD, A DEEP NEURAL NETWORK FOR CIRRHOSIS DETECTION IN LIVER ULTRASOUND (USD) IMAGES
DIEGO ARUFE, Pablo Gomez del Campo, Ezequiel Demirdjian, Carlos Galmarini
Ann Hepatol. 2024;29 Supl 3:101595.87
Acceso a texto completo
P-69 EFFECTS OF POPULATIONAL-RELEVANT DOSES OF CARBOXYMETHYLCELLULOSE AND POLYSORBATE 80 EMULSIFIERS ON MASLD-ASSOCIATED HEPATOCARCINOGENESIS
GABRIEL BACIL PRATA, Julia Noveti Oliveira, Heloiza Ferreira Alves, Guilherme Romualdo Ribeiro, Luis Fernando Barbisan
Ann Hepatol. 2024;29 Supl 3:101595.88
Acceso a texto completo
P-70 ALCOHOL CONSUMPTION RECURRENCE IN LIVER TRANSPLANT PATIENTS WITH ALCOHOLIC CIRRHOSIS: HEALTH AND SOCIAL IMPACT
Fernando Cairo, Lucia Navarro, Ignacio Roca, Ana Saracho, Nicolas Dominguez, Omar Galdame, Manuel Barbero
Ann Hepatol. 2024;29 Supl 3:101595.89
Acceso a texto completo
P-71 BARIATRIC SURGERY AND THE IMPACT ON THE LIVER. COHORT STUDY OF ONE CENTER IN ARGENTINA
Maria Mercedes Cortese, Lucas Muñoz, Gabriel Rifrani, Natalia Ahumada, Daiana Arnedillo, Antonella Cordone, Morena Carvalho, Martina Rigoni, ... Fernando Bessone
Ann Hepatol. 2024;29 Supl 3:101595.90
Acceso a texto completo
P-72 HEPATITIS B AND C VIRUS PREVALENCE USING RAPID TEST IN A CHILEAN COHORT
Javier Eduardo Pérez Valenzuela, Franco Antonio Weisser Vuskovic, Freddy Siegel, Herman Aguirre, Jaime Poniachik, Gonzalo Vizueta, Elizabeth Araya, Juan Rozas, ... Gabriel Mezzano Puentes
Ann Hepatol. 2024;29 Supl 3:101595.91
Acceso a texto completo
P-73 NORADRENALINE IN THE TREATMENT OF HEPATORENAL SYNDROME TYPE AKI: RESULTS IN NON-ICU HOSPITAL SETTING
Zuly Plácido Damián, Javier Diaz Ferrer, Giancarlo Perez Lazo
Ann Hepatol. 2024;29 Supl 3:101595.92
Acceso a texto completo
P-74 GLYCOSYLATED HEMOGLOBIN LEVELS AS A PREDICTOR OF HEPATIC FIBROSIS DUE TO MASLD
Stefanny Cornejo Hernández, Esly Esquivel Alarcón, Reyna Hernández Espinoza, Juan Salvador García Hernández, Mayra Gabriela García Araiza, Trinidad Baldovinos Hernández, Javier Bastida Alquicira, Eira Cerda Reyes, Adriana Martinez Cuazitl
Ann Hepatol. 2024;29 Supl 3:101595.93
Acceso a texto completo
P-75 INFLUENCE OF THE ARTERIAL HEPATIC FLOW IN ELASTOGRAPHY (2D SHEARWAVE) LIVER VALUES
Diego Arufe, Nancy Cordero, Edgar Suarez, Ezequiel Demirdjian
Ann Hepatol. 2024;29 Supl 3:101595.94
Acceso a texto completo
P-76 MANIFESTATIONS OF PORTAL HYPERTENSION IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY: PRELIMINARY DATA
VERONICA GUIDO, Belen Russo, Daniela Chiodi, Nelia Hernandez
Ann Hepatol. 2024;29 Supl 3:101595.95
Acceso a texto completo
P-77 TRIPLE THERAPY FOR DIFFICULT-TO-TREAT PRIMARY BILIARY CHOLANGITIS: A SYSTEMATIC REVIEW AND SINGLE-ARM META-ANALYSIS
Eliabe Silva de Abreu, Deivyd Vieira Silva Cavalcante, Jaqueline Cardoso Habib, Jorge Ferreira Jasmineiro Pitanga, Ana Clara Felix de Farias Santos, Guilherme Grossi Lopes Cançado
Ann Hepatol. 2024;29 Supl 3:101595.96
Acceso a texto completo
P-78 DECOMPENSATED CIRRHOSIS IN A LARGE MULTINATIONAL COHORT IN LATIN AMERICA: MORTALITY IS TOO HIGH IN THE REGION REGARDLESS OF ETIOLOGY AND COUNTRY
Mario Alvares-Da-Silva Reis, Aldo Torre, Carlos Benitez, Jacqueline Cordova-Gallardo, Alberto Farias Queiroz, Sarai Gonzalez-Hueso, Rene Male Velazquez, Sebastian Marciano, ... Jasmohan Bajaj S
Ann Hepatol. 2024;29 Supl 3:101595.97
Acceso a texto completo
P-79 CHARACTERISTICS AND OUTCOMES OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) RECIPIENTS IN A TERTIARY HOSPITAL. LIMA - PERU (JANUARY 2019 - MARCH 2024)
Ricardo Alejandro Rocha Bolaños, Maria Grazia Venturelli Romero, Judy Melissa Piscoya Moncada, Maria Cecilia Cabrera Cabrejos, Lidia Veronica Paz Sihuas, Pedro Martin Padilla Machaca, Gustavo Cesar Araujo Almeyda, Miguel Angel Bedriñana Gomez, Sheyla Carolina Alfaro Ita
Ann Hepatol. 2024;29 Supl 3:101595.98
Acceso a texto completo
P-80 RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS AFTER LIVER TRANSPLANTATION: RESULTS FROM THE BRAZILIAN CHOLESTASIS CONSORTIUM
Paulo Lisboa Bittencourt, Mateus Jorge Nardelli, Luísa Leite Barros, Guilherme Grossi Lopes Cançado, Eduardo Luiz Rachid Cançado, Débora Raquel Benedita Terrabuio, Cristiane Alves Villela-Nogueira, Maria Lucia Gomes Ferraz, ... Claudia Alves Couto
Ann Hepatol. 2024;29 Supl 3:101595.99
Acceso a texto completo
P-81 LIVER TRANSPLANTATION FOR PRIMARY BILIARY CHOLANGITIS (PBC): 25-YEAR EXPERIENCE.
Manuella Sobral Andrade Oliveira, Thaís Assis Vilela, Marcus Vinícius Gomes Acevedo Garcia, Michelle Braga Harriz, Luiz Augusto D'Albuquerque Carneiro, Eduardo Luiz Cançado Rachid, Débora Raquel Terrabuio Benedita
Ann Hepatol. 2024;29 Supl 3:101595.100
Acceso a texto completo
P-82 IMPACT OF HEPATITIS C VIRUS ERADICATION WITH DIRECT ANTIVIRAL DRUGS ON GLYCEMIC CONTROL AFTER LIVER TRANSPLANTATION
Alicia Araújo de Oliveira, Samanta Teixeira Bastos, Claudia Cristina Tavares de Souza, Eduardo de Souza Martins Fernandes, Henrique Sérgio Moraes Coelho, Cristiane Villela-Nogueira, Nathalie Carvalho Leite
Ann Hepatol. 2024;29 Supl 3:101595.101
Acceso a texto completo
P-83 REDUCTION OF LIVER STIFFNESS AFTER ANTICOPPER THERAPY IN WILSON'S DISEASE
Maria Chiara Chindamo, Vivian Rotman, Nathalia Carrano Eduardo de Castro, Debora Canoilas, Marcela Giannini Costa, Mariana Costa de Almeida, Andreia Silva Evangelista, Ubiratan Cassano Santos, ... Renata de Mello Perez
Ann Hepatol. 2024;29 Supl 3:101595.102
Acceso a texto completo
P-84 HAVE CFTR MODULATORS CHANGED THE NEED FOR LIVER TRANSPLANTATION AMONG PATIENTS WITH CYSTIC FIBROSIS? AN ANALYSIS OF THE UNOS DATABASE
MANUEL MENDIZABAL, Claire Cywes, Nicolas Muñoz, Amay Banker, Christian Bermudez, Denis Hadjiliadis, Peter Abt
Ann Hepatol. 2024;29 Supl 3:101595.103
Acceso a texto completo
P-85 IMPACT OF TECHNICAL NOTE No 32/2021 ON THE RATE OF LIVER TRANSPLANTS FOR REFRACTORY ASCITIS IN A TERTIARY HOSPITAL
Guilherme Massote Fontanini, Juarez Roberto de Oliveira Vasconcelos, Marcia Guimarães Villanova, Fernanda Fernandes Souza, Roberta Chaves Araújo, Rebbeca Dias Zaia, Mariana Carvalho Caleffi, Gustavo Pereira Peixoto, Isabela Dourado de Carvalho
Ann Hepatol. 2024;29 Supl 3:101595.104
Acceso a texto completo
P-86 SHORT TERM RESULTS OF TRANSPLANTED ACLF PATIENTS IN A YOUNG TRANSPLANT PROGRAM IN CHILE
Matias Sanhueza Montequin, Nicole Mac-Guire Macchiavello, Giovanna Zavadzki Albuquerque, Vicente Gonzalez Isla, Jose Tomas Leyton Bustamante, Valeria Galaz Kutulas, Elizabeth Rivas Garrido, Julio Benitez Perez, ... Blanca Norero Muñoz
Ann Hepatol. 2024;29 Supl 3:101595.105
Acceso a texto completo
P-87 TRANSCULTURAL ADAPTATION OF THE MEDITERRANEAN DIET TO THE DIETARY HABITS OF EACH GEOGRAPHICAL REGION OF ARGENTINA FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Maria Adela Crosetti, Alejandra Maynat, Andrea Zúñiga
Ann Hepatol. 2024;29 Supl 3:101595.106
Acceso a texto completo
P-88 rs641738 MBOAT7 POLYMORPHISM AS A PREDICTOR OF FIBROSIS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Sofia Rocha, Claudia P. Oliveira, José Tadeu Stefano, Raymundo Soares Azevedo, Isabel Veloso Alves Pereira, Michele Gouvea, Patrícia Momoyo Zitelli, Mário Guimarães Pessoa, João Renato Rebello Pinho
Ann Hepatol. 2024;29 Supl 3:101595.107
Acceso a texto completo
P-89 ADHERENCE TO IMMUNOSUPPRESSIVE THERAPY IN LIVER TRANSPLANT PATIENTS: FACTORS ASSOCIATED TO COMPLIANCE AND IMPACT ON QUALITY OF LIFE
Carol Roa, Daniela Simian, Matías Martínez, Vicente Arancibia, Jaime Poniachik
Ann Hepatol. 2024;29 Supl 3:101595.108
Acceso a texto completo
P-90 COMPARISON BETWEEN MILAN CRITERIA, FRENCH ALPHA-FETOPROTEIN MODEL, AND METROTICKET 2.0 FOR LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.
Victor Nicolas Henriquez Auba, Deycies Ivonne Gaete Letelier, Alvaro Urzúa, Juan Pablo Roblero, Maximo Cattaneo, Lia Catalán, Alexandre Sauré, Solange Adrian, ... Jaime Poniachik
Ann Hepatol. 2024;29 Supl 3:101595.109
Acceso a texto completo
P-91 NORMALIZATION OF ALKALINE PHOSPHATASE COMPARED TO CONVENTIONAL RESPONSE CRITERIA LEADS TO LOWER LIVER RELATED EVENTS AND MORTALITY IN PATIENTS LIVING WITH PRIMARY BILIARY CHOLANGITIS, TREATED WITH UDCA: A RETROSPECTIVE, PROPENSITY SCORED-MATCHED, COHORT STUDY
LUIS ALEJANDRO ROSALES RENTERIA, José David Prieto Nava, Giovanni Francisco Pérez Roa, María Saraí González Huezo
Ann Hepatol. 2024;29 Supl 3:101595.110
Acceso a texto completo
P-92 CAN HONEY AND APICULTURAL DERIVATIVES HELP IN FATTY LIVER DISEASE?
Liena Martina Bravo Urquiza, Marcelo Andia Kohnenkampf, Raquel Bridi, Juan Esteban Oyarzun Isamitt
Ann Hepatol. 2024;29 Supl 3:101595.111
Acceso a texto completo
P-93 DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION IN A PUBLIC HOSPITAL IN CHILE BETWEEN YEARS 2015 AND 2022
Herman Aguirre Barahona, Marisol Arratia Pinto, Javier Perez Valenzuela, Belen Soler Masferrer, Camila Lazcano Jorquera, Joaquin Thomas Pozo, Lilian Isla Montoya, Gabriel Mezzano Puentes
Ann Hepatol. 2024;29 Supl 3:101595.112
Acceso a texto completo
P-94 MICROBIOLOGY OF INFECTIONS IN PATIENTS WITH LIVER CIRRHOSIS HOSPITALIZED AT THE CLINICAL HOSPITAL OF THE UNIVERSITY OF CHILE
Allyson Cid Alcayaga, Pamela Gil Galleguillos, Delfina Pradelli Mancino, Josefa Fonck Rojas, Rocío Jofré Zubicueta, Daniela Simian Marín, Francisco Silva Ojeda, Juan Pablo Roblero Cum
Ann Hepatol. 2024;29 Supl 3:101595.113
Acceso a texto completo
P-95 SARCOPENIA: RISK FACTOR FOR MORTALITY IN CIRRHOTIC PATIENTS ON WAITING LIST FOR LIVER TRANSPLANTATION IN A REFERENCE CENTER, COLOMBIA
Gustavo Andres Diaz Nassif, Geovanny Hernandez Cely
Ann Hepatol. 2024;29 Supl 3:101595.114
Acceso a texto completo
P-96 LONG-TERM PIOGLITAZONE TREATMENT AND LIVER STIFFNESS IN MASLD PATIENTS: INSIGHTS FROM A MULTICENTRIC STUDY
Mario Guimarães Pessoa, ISABEL VELOSO ALVES PEREIRA, Patricia Momoyo Yoshimura Zitelli, Mísia Joyner de Sousa Dias Monteiro, Claudia Couto, Juliana Souza de Oliveira, Ana Beatriz Souza de Oliveira, José Tadeu Stefano, ... Claudia P Oliveira
Ann Hepatol. 2024;29 Supl 3:101595.115
Acceso a texto completo
P-97 THE ROLE OF PSYCHOLOGICAL STRESS IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE. A PILOT STUDY
Larissa Aleman Franco, Paula Gonzalez Sandoval, Mauro Rojas Zúñiga, Nicolas Ortiz López, Maximo Cattaneo Buteler, Juan Pablo Roblero Cum, Jaime Poniachik Teller, Caroll J Beltrán Muñoz
Ann Hepatol. 2024;29 Supl 3:101595.116
Acceso a texto completo
P-98 LACTATE/ALBUMIN RATIO AS A MARKER OF MORTALITY IN PATIENTS HOSPITALIZED WITH ACUTE ON CHRONIC LIVER FAILURE IN A MEXICAN HOSPITAL: CLINICAL ANALYSIS AND PERSPECTIVES
Gabriela Bretón Arroy, Lucia Amairani Robles Casanova, Moises Coutiño Flores, María Del Rosario Herrero Maceda, Scherezada María Isabel Mejia Loza
Ann Hepatol. 2024;29 Supl 3:101595.117
Acceso a texto completo
P-99 CHARACTERIZATION OF PATIENTS WITH LIVER CIRRHOSIS, ITS COMPLICATIONS AND SURVIVAL.
Dayron Páez Suárez, Juan Ramón Pineda Paz, Mayra Zoa Más Martínez, Enrique Rogelio Arús Soler, Gabriel Gonzalo Astorga Moreno, Rhonda Savitri Mohan
Ann Hepatol. 2024;29 Supl 3:101595.118
Acceso a texto completo
P-100 CORRELATION OF TWO TRANSIENT ELASTOGRAPHY EQUIPMENT FOR ESTIMATION OF LIVER STEATOSIS AND LIVER FIBROSIS
Raul Alfonso Gomez Mendoza, Eva Juarez Hernandez, Montserrat Berrospe Alfaro, Regina Lopez De Cardenas Rojo, Martha Helena Ramos Ostos, Graciela Castro Narro, Ivan Lopez Mendez
Ann Hepatol. 2024;29 Supl 3:101595.119
Acceso a texto completo
P-101 PHYSICAL AND NUTRITIONAL INTERVENTION EFFECTIVELY REDUCED FRAILTY IN PATIENTS WITH CIRRHOSIS LISTED FOR LIVER TRANSPLANTATION. RANDOMIZED, CONTROLLED TRIAL.
CARLOS BENÍTEZ GAJARDO, Catalina Grandy, Isidora Cerda, Nicolás Lavados, Nicole Kim, Diego Reyes, Anny Galvez, Silvana Valdés, ... Cecilia Besa
Ann Hepatol. 2024;29 Supl 3:101595.120
Acceso a texto completo
P-102 PERFORMANCE OF NONINVASIVE METHODS TO GRADUATE FIBROSIS AND INFLAMMATION IN A GROUP OF PATIENTS WITH AUTOIMMUNE HEPATITIS
VIVIAN ROTMAN, ANDREIA SILVA EVANGELISTA, MARIA CHIARA CHINDAMO, ALINE MOURA FERRAZ, Nathalia Carraro, Debora Canoilas, Lais Souza Veiga, Rebecca Nogueira Matos, ... Renata M Perez
Ann Hepatol. 2024;29 Supl 3:101595.121
Acceso a texto completo
P-103 AN ELEVATED BASELINE LEVEL OF ALKALINE PHOSPHATASE, ALANINE AMINOTRANSFERASE, AND ASPARTATE AMINOTRANSFERASE PREDICT A LACK OF BIOCHEMICAL RESPONSE TO UDCA THERAPY AMONG HISPANIC PATIENTS LIVING WITH PRIMARY BILIARY CHOLANGITIS
LUIS ALEJANDRO ROSALES RENTERIA, José David Prieto Nava, Giovanni Francisco Pérez Roa, César Salcido Yáñez, Adrián Sandez Araiza, María Saraí González Huezo
Ann Hepatol. 2024;29 Supl 3:101595.122
Acceso a texto completo
P-104 PREVALENCE AND SEVERITY OF MASLD AND ITS ASSOCIATION WITH METABOLIC COMORBIDITIES: INSIGHTS FROM A LINKAGE TO CARE PROGRAM FOR FATTY LIVER DISEASE
Ignacio Roca, Omar Galdame, Maria Del Carmen Puente, Nicolas Dominguez, Rocío Del Carmen Chávez Gonzáles, Manuel Barbero, Lucia Navarro, Fernando Cairo
Ann Hepatol. 2024;29 Supl 3:101595.123
Acceso a texto completo
P-105 RISK FACTORS FOR MORTALITY IN PATIENTS WITH DECOMPENSATED CIRRHOSIS DURING HOSPITALIZATION
Diego Fernando Abendaño Rivera, Cristian Yamin Sánchez Sánchez, Karina Cazarin Chávez, Daniel Santana Vargas, Fátima Higuera De la Tijera, Jose Luis Pérez Hernandez
Ann Hepatol. 2024;29 Supl 3:101595.124
Acceso a texto completo
P-106 DIAGNOSTIC ACCURACY OF SHEAR-WAVE ELASTOGRAPHY IN METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE, A SINGLE CENTER REPORT
LUIS CARLOS ARAYA ACERO, Esteban Ruiz Blard
Ann Hepatol. 2024;29 Supl 3:101595.125
Acceso a texto completo
P-107 CLINICAL SPECTRUM OF METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN PATIENTS WITH ALTERED ANKLE-BRACHIAL INDEX (ABI) AND CARDIOVASCULAR (CV) RISK FACTORS.
Diana Karen Tapia Calderón, Francisco Alejandro Félix Téllez, Sergio Cerpa Cruz, José Roberto Barrientos Ávalos, José Antonio Velarde Chávez, Eliana Carolina Morel Cerda, Juan Manuel Aldana Ledesma, Edgar Santino García Jiménez, José Antonio Velarde Ruiz Velasco
Ann Hepatol. 2024;29 Supl 3:101595.126
Acceso a texto completo
P-108 MAFLD-S SCORE: A CONVENIENT CLINICAL TOOL FOR PREDICTING MASLD IN PRIMARY CARE SETTINGS
JUAN ADRIÁN TORRES DÍAZ, ANTONIO OLIVAS MARTÍNEZ, JESÚS ALEJANDRO RUIZ MANRÍQUEZ, LUIS FEDERICO USCANGA DOMÍNGUEZ, LUIS CARLOS CHÁVEZ GARCÍA, ASHUIN KAMMAR GARCÍA, SOPHIA EUGENIA MARTÍNEZ VÁZQUEZ
Ann Hepatol. 2024;29 Supl 3:101595.127
Acceso a texto completo
P-109 ALKALINE PHOSPHATASE AND CIRRHOSIS AT DIAGNOSIS ARE ASSOCIATED WITH DEEP RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS
Guilherme Grossi Lopes Cançado, Patricia Fucuta, Nathalia Mota de Faria Gomes, Claudia Alves Couto, Eduardo Luiz Rachid Cançado, Debora Raquel Benedita Terrabuio, Cristiane Alves Villela-Nogueira, Michelle Harriz Braga, ... Maria Lúcia Gomes Ferraz
Ann Hepatol. 2024;29 Supl 3:101595.128
Acceso a texto completo
P-110 CHANGES IN THE CLINICAL PRESENTATION OF PRIMARY BILIARY CHOLANGITIS (PBC) OVER THE YEARS IN A UNIVERSITY CENTER IN ARGENTINA
Matías Sebastián Bori, Juan Antonio Sordá, Ilse Sorena Pardo Ivirico, Carolina Garrafa, Esteban González Ballerga
Ann Hepatol. 2024;29 Supl 3:101595.129
Acceso a texto completo
P-111 CHARACTERIZATION OF PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, IN TWO REFERENCE CENTERS, FROM 2011 TO 2023
Lorena Sofía Martínez Bogado, Sara Melgarejo, Maisa Vallejos, Edith Martínez, Claudia Crovato Jimenez, Sebastián Burró, Karina Riquelme, Sergio Morínigo, ... Jesús Ortiz Villalba
Ann Hepatol. 2024;29 Supl 3:101595.130
Acceso a texto completo
P-112 ADVANCED FIBROSIS IN PATIENTS WITH LIVER STEATOSIS MEASURED BY FIBROSCAN AND ITS ASSOCIATED FACTORS
Máximo Cattaneo, Daniela Simian, Katherine Rojas, Jaime Poniachik
Ann Hepatol. 2024;29 Supl 3:101595.131
Acceso a texto completo
P-113 EVALUATION OF THE MELNA AGIB SCALE TO PREDICT MORTALITY IN PATIENTS WITH CIRRHOSIS AND VARICEAL HEMORRHAGE
Miguel Yael Carmona Castillo, Claudia Leticia Dorantes Nava, María De Fatima Higuera De La Tijera, Jose Luis Pérez Hernández
Ann Hepatol. 2024;29 Supl 3:101595.132
Acceso a texto completo
P- 114 CLINICAL CHARACTERIZATION OF CIRRHOTIC PATIENTS HOSPITALIZED AT THE CARDIOINFANTIL FOUNDATION: A NEW PERSPECTIVE
Daniel Rojas Kozhakin, Ximena Morales Cruz, Lina Dorado Delgado, Ana Barragan Gonzalez, Martin Garzon Olarte
Ann Hepatol. 2024;29 Supl 3:101595.133
Acceso a texto completo
P-115 HLA-DRB1*03 /HLA-DRB1*12 ARE ASSOCIATED WITH AUTOIMMUNE HEPATITIS IN A HISPANIC ADULT POPULATION
Adriana Varon Puerta, Luisa Fernanda Santos Cuervo, Rodrigo Cabrera, Angela Baron, Ana Maria Perdomo Arciniegas, Oscar Alfredo Beltran Galvis
Ann Hepatol. 2024;29 Supl 3:101595.134
Acceso a texto completo
P-116 PREDICTION OF CIRRHOSIS THROUGH THE VELOCITY TIME INTEGRAL OF PORTAL VEIN TRACE
Diego Arufe, Ezequiel Demirdjian, Nancy Cordero, Edgar Suarez
Ann Hepatol. 2024;29 Supl 3:101595.135
Acceso a texto completo
P-117 CONTINUOUS INTRAVENOUS TACROLIMUS FOR LIVER TRANSPLANT RECIPIENTS: IMPLEMENTATION STRATEGY AND CLINICAL OUTCOMES
CAMILO ANDRES TORRES LONDOÑO, ANDRES FERNANDO RODRIGUEZ GUTIERREZ, Josefina Pages, Alejandra Estefania Calizaya Astoraque, Marcelo Silva, Federico Piñero, Martin Fauda, MANUEL MENDIZABAL
Ann Hepatol. 2024;29 Supl 3:101595.136
Acceso a texto completo
P-118 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: INDICATION FOR LIVER TRANSPLANTATION AND OCCURRENCE IN THE POSTOPERATIVE PERIOD
Felipe Ramos Caprini, Guilherme Massote Fontanini, Juarez Roberto de Oliveira Vasconcelos, Fernanda Fernandes Souza, Ajith Kumar Sankarankutty, Marcia Guimarães Villanova, Roberta Chaves Araújo
Ann Hepatol. 2024;29 Supl 3:101595.137
Acceso a texto completo
P-119 POST-TRANSPLANT OVERALL AND GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION FOR AUTOIMMUNE HEPATITIS
Ludmila Guedes Resende, Francisco Guilherme Penna Cancela, Fernanda Maria Osório Farage, Luciana Faria Costa, Daniel Antônio Terra Albuquerque, Artur Miranda M C, Guilherme Grossi Cancado, Cláudia Couto Alves
Ann Hepatol. 2024;29 Supl 3:101595.138
Acceso a texto completo
P-120 POLYMORPHISMS OF HLA (LOCI DR 4*) IN HISPANICS AS RISK FACTOR FOR DE-NOVO AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION
Adriana Varon Puerta, Luisa Fernanda Santos Cuervo, Oscar Alfredo Beltran Galvis, Martin Alonso Garzon Olarte, Cristina Torres, Jairo Rivera, Gilberto Andres Mejia
Ann Hepatol. 2024;29 Supl 3:101595.139
Acceso a texto completo
P-121 SEPTIC SHOCK IN LIVER CIRRHOSIS: A COHORT STUDY OF A UNIVERSITY HOSPITAL IN CHILE
Carlos Padilla, Eduardo Villa, Daniela Simian, Juan Nicolás Medel, Victoria Estrada, Sofía Ruiz-Tagle, Juan Grant, María Paz Piñeiro, ... Jaime Poniachik
Ann Hepatol. 2024;29 Supl 3:101595.140
Acceso a texto completo
P-122 HELICOBACTER PYLORI AS A RISK FACTOR FOR ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
Ana Emilia Jiménez Partida, Miguel Ángel Jiménez Luevano, Alejandro Bravo Cuellar, Yolanda Cortés Aguilar, Miguel Ángel Jiménez Partida
Ann Hepatol. 2024;29 Supl 3:101595.141
Acceso a texto completo
P-123 CLINICAL COURSE OF PATIENTS WITH CHOLESTATIC LIVER DISEASES IN A LIVER TRANSPLANT CENTER
Harlim Rodríguez Rodríguez, Marcia Samada Suarez, Teresita Perez Gonzalez, Kenia Y. Valenzuela Aguilera, Lisset Barroso Marquez
Ann Hepatol. 2024;29 Supl 3:101595.142
Acceso a texto completo
P-124 ASSOCIATED FACTORS WITH CLINICAL COURSE OF VASCULAR LIVER DISEASE IN A PUBLIC HOSPITAL IN PERU
CESAR CASTRO VILLALOBOS, Alexandra Linares Tang, Sheyla Ludeña Pacheco, Rosario Mayorga Márquez, Jorge Garavito Rentería, Rommel Zambrano Huilla
Ann Hepatol. 2024;29 Supl 3:101595.143
Acceso a texto completo
P-125 FACTORS ASSOCIATED WITH THE DEVELOPMENT OF POST-BANDING ULCER BLEEDING IN PATIENTS WITH CIRRHOSIS.
Sandra Teutli Carrión, Maria De Fatima Higuera De La Tijera, Juan Carlos Silis Cravioto, Julio Cesar Zavala Castillo
Ann Hepatol. 2024;29 Supl 3:101595.144
Acceso a texto completo
Publique en
Annals of Hepatology
Affiliated societies
